Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients

Alex I. Aspinall; Abdel A. Shaheen; Golasa S. Kochaksaraei; Breean Haslam; Samuel S. Lee; Gisela Macphail; Jeff Kapler; Oscar E. Larios; Kelly W. Burak; Mark G. Swain; Meredith A. Borman; Carla S. Coffin

doi:10.9778/cmajo.20170059

Research

Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients

Alex I. Aspinall, Abdel A. Shaheen, Golasa S. Kochaksaraei, Breean Haslam, Samuel S. Lee, Gisela Macphail, Jeff Kapler, Oscar E. Larios, Kelly W. Burak, Mark G. Swain, Meredith A. Borman and Carla S. Coffin

January 05, 2018 6 (1) E12-E18; DOI: https://doi.org/10.9778/cmajo.20170059

Alex I. Aspinall

Calgary Liver Unit (Aspinall, Shaheen, Kochaksaraei, Haslam, Lee, Burak, Swain, Borman, Coffin), Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary; Calgary Urban Project Society (Macphail); Southern Alberta Clinic (Kapler, Larios, Coffin), Alberta Health Services, Calgary, Alta.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Abdel A. Shaheen

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Golasa S. Kochaksaraei

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Breean Haslam

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Samuel S. Lee

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gisela Macphail

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jeff Kapler

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Oscar E. Larios

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Kelly W. Burak

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark G. Swain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Meredith A. Borman

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Carla S. Coffin

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Tables
Related Content
Metrics
Responses
PDF

Article Information

vol. 6 no. 1 E12-E18

DOI

https://doi.org/10.9778/cmajo.20170059

PubMed

29305405

History

Published online January 5, 2018.

Author Information

Alex I. Aspinall, MD, PhD,
Abdel A. Shaheen, MD,
Golasa S. Kochaksaraei, MD,
Breean Haslam, BN, RN,
Samuel S. Lee, MD,
Gisela Macphail, MD,
Jeff Kapler, PharmD,
Oscar E. Larios, MD,
Kelly W. Burak, MD,
Mark G. Swain, MD,
Meredith A. Borman, MD,
Carla S. Coffin, MD, MSc

Affiliations: Calgary Liver Unit (Aspinall, Shaheen, Kochaksaraei, Haslam, Lee, Burak, Swain, Borman, Coffin), Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary; Calgary Urban Project Society (Macphail); Southern Alberta Clinic (Kapler, Larios, Coffin), Alberta Health Services, Calgary, Alta.

Correspondence to:
Alex Aspinall, aaspinal{at}ucalgary.ca

View Full Text

Usage statistics: January 2018 to October 2021

	Abstract	Full	Pdf
Jan 2018	272	249	105
Feb 2018	151	115	38
Mar 2018	145	72	26
Apr 2018	68	49	24
May 2018	37	20	12
Jun 2018	15	16	7
Jul 2018	18	12	7
Aug 2018	20	13	6
Sep 2018	29	10	6
Oct 2018	21	26	15
Nov 2018	17	26	54
Dec 2018	16	12	13
Jan 2019	15	8	9
Feb 2019	13	14	13
Mar 2019	31	11	15
Apr 2019	7	11	14
May 2019	8	13	9
Jun 2019	21	7	10
Jul 2019	3	1	6
Aug 2019	13	7	5
Sep 2019	12	7	6
Oct 2019	17	9	7
Nov 2019	11	5	5
Dec 2019	12	3	4
Jan 2020	12	5	2
Feb 2020	6	3	2
Mar 2020	9	4	9
Apr 2020	6	0	5
May 2020	11	1	13
Jun 2020	10	2	16
Jul 2020	4	1	2
Aug 2020	7	5	11
Sep 2020	13	3	8
Oct 2020	21	4	14
Nov 2020	11	14	10
Dec 2020	9	3	9
Jan 2021	3	2	4
Feb 2021	8	3	6
Mar 2021	14	2	4
Apr 2021	12	2	5
May 2021	12	3	6
Jun 2021	6	2	4
Jul 2021	2	12	2
Aug 2021	0	6	2
Sep 2021	3	7	10
Oct 2021	0	11	12

PreviousNext

In this issue

Vol. 6, Issue 1

1 Jan 2018

Table of Contents
Index by author

Article tools

Respond to this article

Download PDF

Article Alerts

User Name *

Password *

To sign up for email alerts or to access your current email alerts, enter your email address below:

Email *

Email Article

Thank you for your interest in spreading the word on CMAJ Open.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients

Message Subject (Your Name) has sent you a message from CMAJ Open

Message Body (Your Name) thought you would like to see the CMAJ Open web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients

Jan 2018, 6 (1) E12-E18; DOI: 10.9778/cmajo.20170059

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients